Literature DB >> 10090159

Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.

L Gonzalez-Lopez1, J I Gamez-Nava, G S Jhangri, C Ramos-Remus, A S Russell, M E Suarez-Almazor.   

Abstract

OBJECTIVE: Palindromic rheumatism is characterized by attacks of acute arthritis of short duration. In the long term, a substantial proportion of patients will develop rheumatoid arthritis (RA) or other connective tissue diseases, but the determinants of subsequent chronic disease have not been adequately established. We identify clinical prognostic factors for the development of RA and other connective tissue diseases in patients with palindromic rheumatism in a retrospective cohort study.
METHODS: The medical records of 4900 patients with arthritis referred from 1986 to 1996 to 3 rheumatologists at an academic center were reviewed. One hundred sixty patients were diagnosed as having palindromic rheumatism. After review, 127 complied with diagnostic criteria for palindromic rheumatism. Disease duration was estimated as time of first attack until the last consultation, or the development of RA or other connective tissue disease. Survival analysis including Cox regression was used to identify clinical variables associated with the risk of developing RA or other connective tissue disease, adjusting for varying disease duration.
RESULTS: Sixty-five percent of the patients were female. Age at onset was 40+/-12 years. Mean disease duration was 6+/-6 years, and mean followup by the rheumatologists was 40+/-45 months. Joints more frequently affected were wrist, knee, and metacarpophalangeal. Forty-three patients (34%) subsequently developed a connective tissue disease including 36 (28%) RA, 3 (2%) systemic lupus erythematosus, and 4 (3%) other connective tissue diseases. In the final Cox regression model the hazard ratio for development of a connective tissue disease in the presence of a positive rheumatoid factor (RF) was 2.9 (p = 0.002), for proximal interphalangeal (PIP) joint involvement 2.4 (p = 0.02), for wrist involvement 2.5 (p = 0.05), for female sex 2.2 (p = 0.05), and for age at onset 1.03 (per year) (p = 0.001). Female patients with positive RF and involvement of the hands had an 8-fold risk of developing disease, compared with patients with one or fewer of these features.
CONCLUSION: Positive RF and early involvement of the wrist and PIP joints predict the subsequent development of RA or other connective tissue disease in patients with palindromic rheumatism, and identify a group of patients at increased risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090159

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Palindromic Rheumatism-Like Migratory Non-Erosive Seronegative Polyarthritis in a Patient With Metastatic Conjunctival Malignant Melanoma.

Authors:  Pınar Doruk Analan
Journal:  Arch Rheumatol       Date:  2015-11-30       Impact factor: 1.472

2.  Antiphospholipid syndrome and palindromic rheumatism: a new possible association.

Authors:  Tatiana Reitblat; Irena Litinsky; Dan Caspi; Ori Elkayam
Journal:  Rheumatol Int       Date:  2004-07-23       Impact factor: 2.631

Review 3.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

4.  Magnetic resonance imaging of palindromic rheumatism.

Authors:  Satoko Ueda; Taro Horino; Kaoru Arii; Tatsuhito Morita; Toshihiro Takao; Kozo Hashimoto
Journal:  Rheumatol Int       Date:  2008-07-29       Impact factor: 2.631

5.  One year outcome of undifferentiated polyarthritis.

Authors:  L M A Jansen; D van Schaardenburg; I E van der Horst-Bruinsma; B A C Dijkmans
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

6.  In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up.

Authors:  Yasser Emad; Ashraf Anbar; Ihab Abo-Elyoun; Nashwa El-Shaarawy; Hadeel Al-Hanafi; Hatem Darwish; Mona Gamil; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2014-03-13       Impact factor: 2.980

7.  The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.

Authors:  Yumi Tani; Takayuki Kishi; Takako Miyamae; Manabu Kawamoto; Yasushi Kawaguchi; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

Review 8.  Palindromic rheumatism as part of the rheumatoid arthritis continuum.

Authors:  Kulveer Mankia; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2019-10-08       Impact factor: 20.543

9.  Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.

Authors:  Ching-Heng Lin; Der-Yuan Chen; Wen-Cheng Chao; Tsai-Ling Liao; Yi-Ming Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

10.  Is palindromic rheumatism amongst children a benign disease?

Authors:  Yonatan Butbul-Aviel; Yosef Uziel; Nofar Hezkelo; Riva Brik; Gil Amarilyo
Journal:  Pediatr Rheumatol Online J       Date:  2018-02-13       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.